[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367747-105":59,"doc-detail-367747-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","phosphoglycerate-kinase-1-as-a-potential-prognostic-biomarker-in-papillary-thyroid-carcinoma","Phosphoglycerate kinase 1 as a potential prognostic biomarker in papillary thyroid carcinoma","","Investigation of papillary thyroid carcinoma focuses on identifying reliable indicators for risk stratification despite the generally favorable prognosis. Phosphoglycerate kinase 1 (PGK1), a glycolytic pathway enzyme implicated in cancer progression, was evaluated in thyroid cancer tissues for links to clinicopathological features, postoperative recurrence, and overall prognosis. In 97 surgically treated PTC patients and additional UALCAN survival analyses, higher PGK1 expression correlated with advanced disease characteristics, increased recurrence, and poorer survival, supporting PGK1 as a potential prognostic biomarker.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/phosphoglycerate-kinase-1-as-a-potential-prognostic-biomarker-in-papillary-thyroid-carcinoma/367747/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/phosphoglycerate-kinase-1-as-a-potential-prognostic-biomarker-in-papillary-thyroid-carcinoma/367747.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study purpose regarding PGK1 in papillary thyroid carcinoma?","Question",{"text":113,"@type":114},"To assess the association between PGK1 expression in thyroid cancer tissues and clinicopathological features, postoperative recurrence, and prognosis in PTC patients.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did PGK1 expression differ between cancerous and adjacent non-cancerous tissues?",{"text":118,"@type":114},"PGK1 expression was higher in cancerous tissues than in adjacent non-cancerous tissues.",{"name":120,"@type":111,"acceptedAnswer":121},"What clinical factors and outcomes were linked to higher PGK1 expression?",{"text":122,"@type":114},"Higher PGK1 expression correlated with poorer differentiation, TNM stages III–IV, lymph node metastasis, tumor diameter ≥1.0 cm, higher recurrence rates, and lower survival after 3-year follow-up. Age, lymph node metastasis, differentiation degree, TNM stage, and tumor diameter were identified as risk factors for poor prognosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},367747,1790211943,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":14,"preview_urls":146},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Original Research PUBLISHED 23 July 2025  \nDOI 10.3389/fphar.2025.1542159  \nOPEN ACCESS  \nEDITED BY  \nChunbo He,  \nFuzhou University, China  \nREVIEWED BY  \nSheng Cai,  \nZhejiang University, China Xuexian Fang,  \nHangzhou Normal University, China Changyou Jiang,  \nFudan University, China  \n*CORRESPONDENCE  \nPei-Pei Liu,  \n [fccliupp@zzu.edu.cn](fccliupp@zzu.edu.cn)  \nRECEIVED 09 December 2024  \nACCEPTED 15 July 2025  \nPUBLISHED 23 July 2025  \nCITATION  \nShi X-Q, Liu X-T, Liu X-H, Geng H-W, Zhang Z, Wang W-Y, Chen X, Zhao X, Jue B-L, Qin B and Liu P-P (2025) Phosphoglycerate kinase 1 as a potential prognostic biomarker in papillary thyroid carcinoma.  \nFront. Pharmacol. 16:1542159 .  \ndoi: 10.3389/fphar.2025.1542159  \nCOPYRIGHT  \n© 2025 Shi, Liu, Liu, Geng, Zhang, Wang, Chen, Zhao, Jue, Qin and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nPhosphoglycerate kinase 1 as a potential prognostic biomarker in papillary thyroid carcinoma  \nXiao-Qing Shi 1, Xiao-Tong Liu 2, Xiao-Hui Liu 3,4, Hui-Wen Geng 3, Zhuo Zhang 5, Wei-Yi Wang 6, Xing Chen 7, Xian Zhao 7,  \nBo-Lin Jue 8, Bo Qin 7 and Pei-Pei Liu 􀀁 3,4*  \n1Department of Clinical Laboratory, The First Afﬁliated Hospital of Zhengzhou University, Key Laboratory of Laboratory Medicine of Henan Province, Zhengzhou, Henan, China, 2Department of Clinical Laboratory, The First Hospital of Yongnian District, Yongnian, Hebei, China, 3Clinical Systems Biology Laboratories, The First Afﬁliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, 4Department of Neurology, The First Afﬁliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, 5Department of Neurology, The First Hospital of Lankao, Kaifeng, Henan, China, 6College of Public Health, Zhengzhou University, Zhengzhou, Henan, China, 7Translational Medical Center, The First Afﬁliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, 8College of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China  \nBackgroud: Papillary thyroid carcinoma (PTC) represents a malignant epithelial tumor characterized with a preference for younger individuals. Despite its generally favorable prognosis, PTC still poses considerable challenges, particularly in regards to the propensity for distant metastasis. As a key enzyme in the glycolytic pathway, phosphoglycerate kinase 1 (PGK1) has been linked to the progression of various cancer types. However, its role in PTC remains to be elucidated. This study aimed to investigate the association between PGK1 expression in thyroid cancer tissues and clinicopathological features, postoperative recurrence, and prognosis to provide clinical assessment and intervention reference.  \nMethods: We investigated the correlation between PGK1 expression and the clinicopathological characteristics, recurrence, and prognosis in 97 PTC patients who underwent surgical treatments between 1 January 2020, and 31 December 2020 in Zhengzhou University First Afﬁliated Hospital. Besides, we also analysed the correlation of PGK1 expression with the 10-year survival rate of patients with thyroid carcinoma (THCA) in UALCAN database.  \nResults: PGK1 expression was higher in cancerous tissues than that in adjacent non-cancerous tissues. Further analysis of PGK1 expression across clinicopathological characteristics revealed that patients with poorly differentiated tumors, TNM stages III–IV, lymph node metastasis, and tumor diameter ≥1. 0 cm exhibited higher PGK1 expression levels in cancerous tissues. A subsequent 3-year postoperative follow-up was conducted to evaluate the correlation between","cbCaicathd0XbXTi","https://ap.wps.com/l/cbCaicathd0XbXTi","pdf",1505258,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Highlights\n# Introduction","[{\"question\":\"What was the study purpose regarding PGK1 in papillary thyroid carcinoma?\",\"answer\":\"To assess the association between PGK1 expression in thyroid cancer tissues and clinicopathological features, postoperative recurrence, and prognosis in PTC patients.\"},{\"question\":\"How did PGK1 expression differ between cancerous and adjacent non-cancerous tissues?\",\"answer\":\"PGK1 expression was higher in cancerous tissues than in adjacent non-cancerous tissues.\"},{\"question\":\"What clinical factors and outcomes were linked to higher PGK1 expression?\",\"answer\":\"Higher PGK1 expression correlated with poorer differentiation, TNM stages III–IV, lymph node metastasis, tumor diameter ≥1.0 cm, higher recurrence rates, and lower survival after 3-year follow-up. Age, lymph node metastasis, differentiation degree, TNM stage, and tumor diameter were identified as risk factors for poor prognosis.\"}]","Phosphoglycerate kinase 1 as a potential prognostic biomarker in papillary thyroid carcinoma | PDF",1790172335,28,[147,151],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/8d2d06df110f00e64bd4eaad0cd8dbfb.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/49022b0d5e99d470784371f67fcd48c5.webp",982,1388]